汉森制药：将密切关注行业动态提升核心竞争力

Group 1 - The company acknowledges the impact of national "anti-involution" and "medical procurement" policies on the industry, suggesting a positive influence on its operations and product effectiveness [1] - The company emphasizes its commitment to closely monitor industry trends and enhance its core competitiveness in response to these policies [1]